Jubilant Pharmova - Quaterly Results

27 Oct 2023 Evaluate
Net sales declined -16.42%  to  Rs. 1863.00 million from Rs. 2229.00 millions.The Net Loss for the quarter ended September 2023 is Rs. -4.00 millions as compared to Net Profit of Rs. 918.00 millions of corresponding quarter ended September 2022A decline of 192.00 millions was observed in the OP in the quarter ended September 2023 from 1134.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1863.00 2229.00 -16.42 4037.00 4275.00 -5.57 8101.20 7257.30 11.63
Other Income 184.00 1062.00 -82.67 343.00 1164.00 -70.53 1378.90 1261.60 9.30
PBIDT 192.00 1134.00 -83.07 393.00 1193.00 -67.06 1411.10 1326.20 6.40
Interest 71.00 41.00 73.17 135.00 73.00 84.93 185.20 109.90 68.52
PBDT 121.00 1093.00 -88.93 258.00 1120.00 -76.96 1225.90 1216.30 0.79
Depreciation 119.00 111.00 7.21 233.00 203.00 14.78 432.50 369.10 17.18
PBT 2.00 982.00 -99.80 25.00 917.00 -97.27 793.40 847.20 -6.35
TAX 6.00 64.00 -90.63 10.00 51.00 -80.39 294.60 42.30 596.45
Deferred Tax 6.00 -80.00 -107.50 6.00 -93.00 -106.45 156.40 -100.50 -255.62
PAT -4.00 918.00 -100.44 15.00 866.00 -98.27 498.80 804.90 -38.03
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.30 159.30 0.00
PBIDTM(%) 10.31 50.87 -79.74 9.73 27.91 -65.12 17.42 18.27 -4.68

Jubilant Pharmova Share Price

1063.05 -29.15 (-2.67%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.